PHASE III STUDY WITH ATEZOLIZUMAB VERSUS PLACEBO IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS AFTER PLEURECTOMY/DECORTICATION
Latest Information Update: 04 Jan 2024
At a glance
- Drugs Atezolizumab (Primary)
- Indications Gilbert's disease; Malignant-mesothelioma
- Focus Therapeutic Use
- Acronyms AtezoMeso
- 13 Aug 2021 New trial record